+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Autacoids And Related Drug Global Market Report 2025

  • PDF Icon

    Report

  • 175 Pages
  • January 2025
  • Region: Global
  • The Business Research Company
  • ID: 6103669
The autacoids and related drug market size has grown strongly in recent years. It will grow from $50.15 billion in 2024 to $53.32 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth during the historic period can be attributed to several factors, including the increasing prevalence of inflammatory diseases, a rising use of prostaglandins in obstetrics, widespread prescription of antihistamines, the expanding applications of serotonin agonists, and higher demand for migraine relief medications.

The autacoids and related drug market size is expected to see strong growth in the next few years. It will grow to $67.64 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth during the forecast period can be attributed to several factors, including the rising geriatric population, growing prevalence of chronic respiratory diseases, adoption of personalized medicine, expanding healthcare access in emerging economies, and the increasing incidence of cardiovascular disorders. Key trends during this period include the integration of artificial intelligence in drug discovery, the development of dual-action autacoid drugs, the adoption of biosimilars for autacoid treatments, growth in self-medication and over-the-counter (OTC) products, and the use of nanotechnology in drug formulation.

The growing prevalence of cardiovascular diseases is expected to drive the expansion of the autacoids and related drugs market in the coming years. Cardiovascular diseases encompass a range of disorders that impact the heart and blood vessels, including coronary heart disease, heart failure, stroke, and hypertension. The rise in cardiovascular diseases is mainly linked to poor dietary habits, with high consumption of saturated fats, trans fats, added sugars, and sodium contributing to high blood pressure, obesity, and elevated cholesterol levels, all of which are significant risk factors for heart-related conditions. Autacoids and related drugs support cardiovascular health by modulating vascular tone and inflammation, both of which are critical in managing hypertension and heart failure. Agents that target pathways involving nitric oxide, endothelin, and prostacyclin aid in restoring endothelial function, promoting vasodilation, and reducing vascular resistance. For instance, in December 2023, the Australian Institute of Health and Welfare reported that the number of doctor-certified deaths due to coronary heart disease (CHD) in Australia rose from 14,100 in 2021 to 14,900 in 2022. Consequently, the increasing prevalence of cardiovascular diseases is fueling the growth of the autacoids and related drugs market.

Leading companies in the autacoids and related drugs market are concentrating on the development of innovative products, such as antihistamines, to enhance therapeutic effectiveness, reduce side effects, and address new allergic and inflammatory conditions with greater accuracy and safety. Antihistamines are medications that block the effects of histamine, a chemical released by the immune system during an allergic reaction. For example, in March 2023, Tiefenbacher Pharmaceuticals, a Germany-based pharmaceutical company, launched Bilastine as an over-the-counter (OTC) medication in Germany, representing a significant advancement in improving access to effective allergy treatments. The 20 mg Bilastine tablets offer a non-sedating, second-generation antihistamine solution for individuals experiencing allergic symptoms such as hay fever and urticaria.

In May 2024, Incyte Corporation, a US-based biopharmaceutical company, completed the acquisition of Escient Pharmaceuticals Inc. for approximately $750 million. This acquisition enables Incyte to expand its immunology portfolio and accelerate the development of novel treatments for pruritus and other inflammatory disorders by integrating Escient Pharmaceuticals' innovative pipeline of first-in-class, small molecule therapeutics targeting Mas-related G protein-coupled receptors (MRGPRs). Escient Pharmaceuticals Inc., a US-based biotechnology company, is focused on developing novel therapeutics that target autacoid-related pathways.

Major players in the autacoids and related drug market are Sanofi S.A., Fresenius SE & Co. KGaA, Dr. Reddy's Laboratories Limited, EUROAPI S.A., Pfizer CentreOne, Cayman Chemical Company, Tokyo Chemical Industry Co. Ltd., Avanti Polar Lipids Inc., Kyowa Pharma Chemical Co. Ltd., Nicox S.A., Glentham Life Sciences Ltd., LGM Pharma Inc., chemBlink Inc., ZellBio GmbH, AquigenBio LLC, BOC Sciences Inc., Yarrow Chem Products Pvt. Ltd., LEBSA S.A., VDK NaturaSyn S.A., Enzo Life Sciences Inc.

North America was the largest region in the autacoids and related drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in autacoids and related drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the autacoids and related drugsmarket report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Autacoids and related drugs are biologically active substances produced by the body that regulate physiological functions locally, typically within specific tissues or organs. They play a role in inflammation, smooth muscle contraction, immune responses, and the regulation of blood flow. Autacoids exert their effects by binding to specific receptors on target cells, triggering signaling pathways that influence cellular activity.

The main types of autacoids and related drugs include histamines, prostaglandins, leukotrienes, serotonin, and bradykinin. Histamines are chemicals released during allergic reactions that lead to symptoms such as itching, swelling, and increased stomach acid. They are targeted in treatments for allergies and acid-related conditions. Drugs aimed at these autacoids can be administered through various routes, such as oral, injectable, topical, intranasal, and inhalation. These treatments are used for a range of applications, including cardiovascular disorders, inflammatory diseases, respiratory disorders, allergies, and gastrointestinal conditions. The primary end users of these treatments include hospitals, clinics, homecare settings, and pharmacies.

The autacoids and related drug market research report is one of a series of new reports that provides autacoids and related drug market statistics, including the autacoids and related drug industry global market size, regional shares, competitors with the autacoids and related drug market share, detailed autacoids and related drug market segments, market trends, and opportunities, and any further data you may need to thrive in the autacoids and related drug industry. This autacoids and related drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The autacoids and related drug market consists of sales of biogenic amines, polypeptide autacoids, lipid-derived autacoids, and leukotrienes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Autacoids And Related Drug Market Characteristics3. Autacoids And Related Drug Market Trends And Strategies4. Autacoids And Related Drug Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Autacoids And Related Drug Growth Analysis And Strategic Analysis Framework
5.1. Global Autacoids And Related Drug PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Autacoids And Related Drug Market Growth Rate Analysis
5.4. Global Autacoids And Related Drug Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Autacoids And Related Drug Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Autacoids And Related Drug Total Addressable Market (TAM)
6. Autacoids And Related Drug Market Segmentation
6.1. Global Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Histamines
  • Prostaglandins
  • Leukotrienes
  • Serotonin
  • Bradykinin
6.2. Global Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Injectable
  • Topical
  • Intranasal
  • Inhalation
6.3. Global Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiovascular Disorders
  • Inflammatory Diseases
  • Respiratory Disorders
  • Allergies
  • Gastrointestinal Disorders
6.4. Global Autacoids And Related Drug Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Homecare
  • Pharmacies
6.5. Global Autacoids And Related Drug Market, Sub-Segmentation Of Histamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • H1 Receptor Antagonists
  • H2 Receptor Antagonists
  • H3 Receptor Antagonists
  • H4 Receptor Antagonists
  • Histamine Agonists
6.6. Global Autacoids And Related Drug Market, Sub-Segmentation Of Prostaglandins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prostaglandin E1 (PGE1) Analogs
  • Prostaglandin E2 (PGE2) Analogs
  • Prostaglandin F2a (PGF2a) Analogs
  • Prostaglandin I2 (PGI2) Analogs
  • Prostaglandin D2 (PGD2) Analogs
6.7. Global Autacoids And Related Drug Market, Sub-Segmentation Of Leukotrienes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Leukotriene Receptor Antagonists (LTRAs)
  • 5-Lipoxygenase Inhibitors
  • Leukotriene Synthesis Inhibitors
6.8. Global Autacoids And Related Drug Market, Sub-Segmentation Of Serotonin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 5-HT1 Receptor Agonists
  • 5-HT2 Receptor Antagonists
  • 5-HT3 Receptor Antagonists
  • 5-HT4 Receptor Agonists
  • 5-HT6 And 5-HT7 Modulators
6.9. Global Autacoids And Related Drug Market, Sub-Segmentation Of Bradykinin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bradykinin B1 Receptor Antagonists
  • Bradykinin B2 Receptor Antagonists
  • Bradykinin Receptor Agonists
7. Autacoids And Related Drug Market Regional And Country Analysis
7.1. Global Autacoids And Related Drug Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Autacoids And Related Drug Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Autacoids And Related Drug Market
8.1. Asia-Pacific Autacoids And Related Drug Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Autacoids And Related Drug Market
9.1. China Autacoids And Related Drug Market Overview
9.2. China Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Autacoids And Related Drug Market
10.1. India Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Autacoids And Related Drug Market
11.1. Japan Autacoids And Related Drug Market Overview
11.2. Japan Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Autacoids And Related Drug Market
12.1. Australia Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Autacoids And Related Drug Market
13.1. Indonesia Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Autacoids And Related Drug Market
14.1. South Korea Autacoids And Related Drug Market Overview
14.2. South Korea Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Autacoids And Related Drug Market
15.1. Western Europe Autacoids And Related Drug Market Overview
15.2. Western Europe Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Autacoids And Related Drug Market
16.1. UK Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Autacoids And Related Drug Market
17.1. Germany Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Autacoids And Related Drug Market
18.1. France Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Autacoids And Related Drug Market
19.1. Italy Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Autacoids And Related Drug Market
20.1. Spain Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Autacoids And Related Drug Market
21.1. Eastern Europe Autacoids And Related Drug Market Overview
21.2. Eastern Europe Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Autacoids And Related Drug Market
22.1. Russia Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Autacoids And Related Drug Market
23.1. North America Autacoids And Related Drug Market Overview
23.2. North America Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Autacoids And Related Drug Market
24.1. USA Autacoids And Related Drug Market Overview
24.2. USA Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Autacoids And Related Drug Market
25.1. Canada Autacoids And Related Drug Market Overview
25.2. Canada Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Autacoids And Related Drug Market
26.1. South America Autacoids And Related Drug Market Overview
26.2. South America Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Autacoids And Related Drug Market
27.1. Brazil Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Autacoids And Related Drug Market
28.1. Middle East Autacoids And Related Drug Market Overview
28.2. Middle East Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Autacoids And Related Drug Market
29.1. Africa Autacoids And Related Drug Market Overview
29.2. Africa Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Autacoids And Related Drug Market Competitive Landscape And Company Profiles
30.1. Autacoids And Related Drug Market Competitive Landscape
30.2. Autacoids And Related Drug Market Company Profiles
30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Dr. Reddy's Laboratories Limited Overview, Products and Services, Strategy and Financial Analysis
30.2.4. EUROAPI S.A. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Pfizer CentreOne Overview, Products and Services, Strategy and Financial Analysis
31. Autacoids And Related Drug Market Other Major And Innovative Companies
31.1. Cayman Chemical Company
31.2. Tokyo Chemical Industry Co. Ltd.
31.3. Avanti Polar Lipids Inc.
31.4. Kyowa Pharma Chemical Co. Ltd.
31.5. Nicox S.A.
31.6. Glentham Life Sciences Ltd.
31.7. LGM Pharma Inc.
31.8. chemBlink Inc.
31.9. ZellBio GmbH
31.10. AquigenBio LLC
31.11. BOC Sciences Inc.
31.12. Yarrow Chem Products Pvt. Ltd.
31.13. LEBSA S.A.
31.14. VDK NaturaSyn S.A.
31.15. Enzo Life Sciences Inc.
32. Global Autacoids And Related Drug Market Competitive Benchmarking And Dashboard33. Key Mergers And Acquisitions In The Autacoids And Related Drug Market34. Recent Developments In The Autacoids And Related Drug Market
35. Autacoids And Related Drug Market High Potential Countries, Segments and Strategies
35.1 Autacoids And Related Drug Market In 2029 - Countries Offering Most New Opportunities
35.2 Autacoids And Related Drug Market In 2029 - Segments Offering Most New Opportunities
35.3 Autacoids And Related Drug Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright And Disclaimer

Executive Summary

Autacoids And Related Drug Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on autacoids and related drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for autacoids and related drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The autacoids and related drug market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Type: Histamines; Prostaglandins; Leukotrienes; Serotonin; Bradykinin
2) By Administration: Oral; Injectable; Topical; Intranasal; Inhalation
3) By Application: Cardiovascular Disorders; Inflammatory Diseases; Respiratory Disorders; Allergies; Gastrointestinal Disorders
4) By End User: Hospitals; Clinics; Homecare; Pharmacies

Subsegments:

1) By Histamines: H1 Receptor Antagonists; H2 Receptor Antagonists; H3 Receptor Antagonists; H4 Receptor Antagonists; Histamine Agonists
2) By Prostaglandins: Prostaglandin E1 (PGE1) Analogs; Prostaglandin E2 (PGE2) Analogs; Prostaglandin F2α (PGF2α) Analogs; Prostaglandin I2 (PGI2) Analogs; Prostaglandin D2 (PGD2) Analogs
3) By Leukotrienes: Leukotriene Receptor Antagonists (LTRAs); 5-Lipoxygenase Inhibitors; Leukotriene Synthesis Inhibitors
4) By Serotonin: 5-HT1 Receptor Agonists; 5-HT2 Receptor Antagonists; 5-HT3 Receptor Antagonists; 5-HT4 Receptor Agonists; 5-HT6 And 5-HT7 Modulators
5) By Bradykinin: Bradykinin B1 Receptor Antagonists; Bradykinin B2 Receptor Antagonists; Bradykinin Receptor Agonists

Key Companies Profiled: Sanofi S.A.; Fresenius SE & Co. KGaA; Dr. Reddy's Laboratories Limited; EUROAPI S.A.; Pfizer CentreOne

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

  • Sanofi S.A.
  • Fresenius SE & Co. KGaA
  • Dr. Reddy's Laboratories Limited
  • EUROAPI S.A.
  • Pfizer CentreOne
  • Cayman Chemical Company
  • Tokyo Chemical Industry Co. Ltd.
  • Avanti Polar Lipids Inc.
  • Kyowa Pharma Chemical Co. Ltd.
  • Nicox S.A.
  • Glentham Life Sciences Ltd.
  • LGM Pharma Inc.
  • chemBlink Inc.
  • ZellBio GmbH
  • AquigenBio LLC
  • BOC Sciences Inc.
  • Yarrow Chem Products Pvt. Ltd.
  • LEBSA S.A.
  • VDK NaturaSyn S.A.
  • Enzo Life Sciences Inc.